Sociedad Americana de Hirudoterapia

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae)

Research article published in Evolutionary bioinformatics online (2026)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportDesarrollo de fármacosHsiao S et al. · Evolutionary bioinformatics online, 2026

Abstract

OBJECTIVE: Species of glossiphoniid leech provide model systems for exploring fundamental questions in evolutionary and developmental biology. In this study, we took advantage of large embryonic cells and stereotypical cleavage patterns in the leech, Helobdella austinensis, to identify genes associated with the births of teloblasts and their lineage specifications. METHODS: Using staged embryos and pools of dissected precursor cells and teloblasts, a systematic computational comparison of staged and cell type-specific transcriptomic data was employed to identify unique gene sets associated with mesodermal (M), neuroectodermal (N) and teloblast (M + N) cell formation. RESULTS AND CONCLUSIONS: Our predicted candidate genes comprised sets of nucleic acid binding factors as anticipated but displayed little similarity with differentiation factors in other metazoans (eg, mammals, cnidarians), suggesting that stem cell/lineage induction processes have diverged across the Animalia and may reflect fundamentally different modes of embryonic development. Leeches are historically well known for bloodletting practices that were widespread throughout the 19th century and were also a classic preparation for neurobiologists during the same period. In modern times they have found medical applications in reconstructive surgeries, wound healing and more recently “hirudotherapy.” Lesser known are the contributions of leeches to embryology and evolution. Here we take advantage of unusually large embryos in the leech, Helobdella autinensis, to isolate homogeneous populations of teloblasts and their immediate precursor cells. By extracting RNA from these different cells, we were able to identify sets of genes that were unique to each cell type. Computational analyses of targeted genes suggest that many are associated with determining stem cell fate and lineage specification (eg, mesoderm, neuroectoderm). Interestingly, however, our predicted gene sets display only marginal similarity with comparable genes in other animals (eg, humans, Hydra), implying that early developmental processes associated with stem cell formation have diverged considerably over the course of animal evolution.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae).

Por qué esto importa para la hirudoterapia

Este estudio utilizó embriones en etapas y células precursoras/teloblastos disecados de la sanguijuela Helobdella austinensis para identificar conjuntos de genes asociados con la formación de células teloblásticas mesodérmicas (M), neuroectodérmicas (N) y combinadas, hallando candidatos de factores de unión a ácidos nucleicos con similitud limitada con genes de diferenciación en otros metazoos. Los autores señalan el papel histórico de las sanguijuelas en las sangrías, el uso moderno en cirugía reconstructiva y cicatrización de heridas, y la reciente «hirudoterapia». Para el dominio de ASH, la conexión es contextual e histórica más que mecanicista: el estudio se refiere a la biología del desarrollo de la sanguijuela y no investiga el secretoma, la hirudina ni la hirudoterapia clínica. ADVERTENCIA: Se trata de un estudio básico de desarrollo/transcriptómica sin datos sobre compuestos salivales de la sanguijuela ni aplicación terapéutica; la relevancia para el dominio central de ASH es indirecta y se limita al contexto del organismo.

Citación

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae)

Hsiao S et al. · Evolutionary bioinformatics online, 2026

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.